Literature DB >> 17969450

Beyond double-stranded RNA-type I IFN induction by 3pRNA and other viral nucleic acids.

M Schlee1, W Barchet, V Hornung, G Hartmann.   

Abstract

Production of type I IFN is the key response to viral infection. Since the discovery of type I IFNs in 1957, long double-stranded RNA formed during replication of many viruses was thought to be responsible for type I IFN induction, and for decades double-stranded RNA-activated protein kinase (PKR) was thought to be the receptor. Recently, this picture has dramatically changed. It now became evident that not PKR but two members of the Toll-like receptor (TLR) family, TLR7 and TLR9, and two cytosolic helicases, RIG-I and MDA-5, are responsible for the majority of type I IFNs induced upon recognition of viral nucleic acids. In this review, we focus on the molecular mechanisms by which those innate immune receptors detect viral infection. Based on the recent progress in the field, we now know that TLR7, TLR9, and RIG-I do not require long double-stranded RNA for type I IFN induction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17969450      PMCID: PMC7120510          DOI: 10.1007/978-3-540-71329-6_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  16 in total

1.  Gene silencing below the immune radar.

Authors:  Gunther Hartmann
Journal:  J Clin Invest       Date:  2009-03       Impact factor: 14.808

2.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 3.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 4.  The chase for the RIG-I ligand--recent advances.

Authors:  Martin Schlee; Gunther Hartmann
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

Review 5.  The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.

Authors:  Décio L Eizirik; Maikel L Colli; Fernanda Ortis
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

Review 6.  A brilliant disguise for self RNA: 5'-end and internal modifications of primary transcripts suppress elements of innate immunity.

Authors:  Subba Rao Nallagatla; Rebecca Toroney; Philip C Bevilacqua
Journal:  RNA Biol       Date:  2008-07-20       Impact factor: 4.652

7.  Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice.

Authors:  Adam D Judge; Marjorie Robbins; Iran Tavakoli; Jasna Levi; Lina Hu; Anna Fronda; Ellen Ambegia; Kevin McClintock; Ian MacLachlan
Journal:  J Clin Invest       Date:  2009-02-23       Impact factor: 14.808

8.  Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143.

Authors:  Matthias Budt; Lars Niederstadt; Ralitsa S Valchanova; Stipan Jonjić; Wolfram Brune
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

9.  Activation of the Antiviral Kinase PKR and Viral Countermeasures.

Authors:  Bianca Dauber; Thorsten Wolff
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

10.  Chemically Modified Oligonucleotides Modulate an Epigenetically Varied and Transient Form of Transcription Silencing of HIV-1 in Human Cells.

Authors:  Stuart Knowling; Kenneth Stapleton; Anne-Marie W Turner; Eugen Uhlmann; Thomas Lehmann; Jörg Vollmer; Kevin V Morris
Journal:  Mol Ther Nucleic Acids       Date:  2012-04-10       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.